Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8901111
SERIAL NO

13375855

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Certain aryl-substituted heterocyclic urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN PHARMACEUTICA NV

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Breitenbucher, J Guy Escondido, US 52 222
Chambers, Alison L San Diego, US 10 22
Hawryluk, Natalie A San Diego, US 20 60
Keith, John M San Diego, US 44 1005
Merit, Jeffrey E Stanford, US 20 88
Tichenor, Mark S San Diego, US 32 93

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 2, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00